The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer progressed on gemcitabine-based therapy.
 
Patrick Grierson
No Relationships to Disclose
 
Andrea Wang-Gillam
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen; Jacobio; Jacobio; Jacobio; Jacobio; Merrimack; Merrimack; Merrimack; Merrimack; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); Aduro Biotech (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BioMed Valley Discoveries (Inst); BioMed Valley Discoveries (Inst); BioMed Valley Discoveries (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); CTI (Inst); CTI (Inst); CTI (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Precision Therapeutics (Inst); Precision Therapeutics (Inst); Precision Therapeutics (Inst); Precision Therapeutics (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Xcovery (Inst); Xcovery (Inst); Xcovery (Inst); Xcovery (Inst)
 
Haeseong Park
Research Funding - Ambrx (Inst); Ambrx (Inst); Ambrx (Inst); Ambrx (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Medivation (Inst); Medivation (Inst); Medivation (Inst); Medivation (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Millennium (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Katrina Pedersen
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer
Speakers' Bureau - Clinical Care Options; Clinical Care Options; Clinical Care Options; Clinical Care Options
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; BeiGene; BeiGene; BeiGene; BeiGene
 
Benjamin R. Tan
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst); Sillajen (Inst); tyrogenex (Inst); tyrogenex (Inst); tyrogenex (Inst); tyrogenex (Inst)
 
Manik A. Amin
Consulting or Advisory Role - AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); AstraZeneca (I); TERUMO (I); TERUMO (I); TERUMO (I); TERUMO (I)
 
Rama Suresh
No Relationships to Disclose
 
Nikolaos Trikalinos
No Relationships to Disclose
 
Jingxia Liu
No Relationships to Disclose